Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05697497
Other study ID # STUDY00016054
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date January 6, 2022

Study information

Verified date August 2023
Source Milton S. Hershey Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a randomized trial of 100 older adults with mobility disability, who performed a similar brief daily, resistance training program. The investigators set out to answer the following question "Will a digital, brief daily exercise program be feasible, acceptable, and effective among older adults with walking limitations?" To answer that question, participants were assigned to an intervention or delayed-treatment control group. Intervention participants were assigned to complete two 30-second lower body exercises and two 30-second upper body exercises. Fitness tests were completed remotely three times during the 12-weeks (i.e., at baseline, week 6, week 12).


Description:

This is a 12-week delayed-control randomized trial to answer the following question "Will a digital, brief daily exercise program be feasible, acceptable, and effective among older adults with walking limitations?" Participants who screen eligible will be assigned to one of four conditions, an immediate workout group, an immediate workout group with activity monitor, a delayed workout group or a delayed workout group with activity monitor. Participants will complete a daily 2.5-to-3.5-minute exercise routine at home and to record their results using an electronic survey. Other outcome measurements will be conducted remotely at baseline, 6, and 12 weeks. The investigators hypothesize that participants in the AMRAP condition will report significant reductions in functional physical limitations, increased gait speed, and increased physical performance (i.e., increased exercise repetitions) from baseline to 6 weeks compared to those randomized to the delayed-treatment control.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date January 6, 2022
Est. primary completion date January 6, 2022
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Age 65 and older - Difficulty with walking - Providers must provide consent for their patient - Access to the internet - Must have a camera on computer, tablet, or smartphone - Fluent in Egnlish Exclusion Criteria: - Chest pain or a heart condition on the PAR-Q - Planning to have surgery in the next 3 months - Cognitive impairment - Unable to exercise - Being currently physically active

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Daily exercise intervention
Participants will complete four exercises each day, The first two weeks they will be instructed to complete as many repetitions as possible, each day, for 15 seconds and progressing to 30 seconds per exercise after the first two weeks. Participants are asked to increase their goal repetitions by 1 or 2 from their previous best each week. For all exercises with modifications, we will encourage participants to move to the next most difficult modification once they can do 15 repetitions of that exercise.

Locations

Country Name City State
United States Penn State Hershey Medical Center Hershey Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Milton S. Hershey Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 30-Second Chair Stand Leg strength and endurance test - number of chair stand repetitions in 30 seconds Baseline
Primary 30-Second Chair Stand Leg strength and endurance test - number of chair stand repetitions in 30 seconds 6 weeks
Primary 30-Second Chair Stand Leg strength and endurance test - number of chair stand repetitions in 30 seconds 12 weeks
Primary Five Time Sit to Stand Test (5TSTS) The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The score is the amount of time (to the nearest decimal in seconds) it takes a patient to transfer from a seated to a standing position and back to sitting five times. Baseline
Primary Five Time Sit to Stand Test (5TSTS) The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The score is the amount of time (to the nearest decimal in seconds) it takes a patient to transfer from a seated to a standing position and back to sitting five times. 6 weeks
Primary Five Time Sit to Stand Test (5TSTS) The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The score is the amount of time (to the nearest decimal in seconds) it takes a patient to transfer from a seated to a standing position and back to sitting five times. 12 weeks
Primary Single Leg Stance Test (SLS) Assessment of static postural and balance control. 12 weeks
Primary Functional limitations Physical Functioning Questionnaire from the National Health and Nutrition Examination Survey 12 weeks
Primary Falls Falls over the past 3 months will be assessed using the Behavioral Risk Factor Surveillance System survey. 12 weeks
Secondary Walking gait cadence Gait cadence will be measured in 50% of the participants using an activPAL device. 10 day period pre and post intervention
Secondary Pain on the Patient Reported Outcomes Measurement Information System (PROMIS) survey Survey using questions from the NIH-supported Patient Reported Outcomes Measurement Information System (PROMIS). The minimal value for pain interference is not at all, while the minimum value for pain intensity is no pain. The maximum value for pain interference is very much, while the maximum value for pain intensity is worst pain imaginable. A higher score generally means a worse outcome. 12 weeks
Secondary Fatigue on the Patient Reported Outcomes Measurement Information System (PROMIS) survey Survey using questions from the NIH-supported Patient Reported Outcomes Measurement Information System (PROMIS). The minimum value for fatigue is not at all, while the maximum value is very much. A higher score generally means a worse outcome. 12 weeks
Secondary Self-Efficay for Physical Activity (SEPA) 5-item measure that assesses an individual's confidence for engaging in exercise in the presence of barriers. 12 weeks
Secondary Percent of sessions attended Patients will be considered adherent to the intervention when they enter their daily exercise performance data via daily survey. The percent of sessions attended will be calculated by dividing the number of sessions attended by the total number of sessions offered and multiplying the result by 100. 12 weeks
Secondary Heart rate resting and maximal heart rates will be collected during the maximal exercise performance tests 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT04997447 - Enforced Reduction in Physical Activity and Recovery in Older Adults N/A
Completed NCT04588558 - Investigation of the Effectiveness of a Structured Squat-based Program in Knee Osteoarthritis Rehabilitation N/A
Completed NCT06003868 - Investigation of the Effect of Hippotherapy Simulator in Children With Spastic Diplegia and Cerebral Palsy N/A
Recruiting NCT04543058 - BeatPark: Self-rehabilitation in Walking With Parkinson's Disease N/A
Completed NCT04553198 - Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery N/A
Not yet recruiting NCT06107556 - Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury
Recruiting NCT04721860 - Optimizing Training in Severe Post-Stroke Walking Impairment N/A
Completed NCT04627558 - Validity Reliability of The Dubousset Functional Test in Stroke Patients
Recruiting NCT05706181 - Heat Therapy, Functional Capacity, and Vascular Health in Older Adults Phase 1/Phase 2
Recruiting NCT05461677 - Walking With the SAIRE Smart Walker N/A
Recruiting NCT05742880 - Effect of Face Masks on Pulmonary Function in Patients With COPD N/A
Recruiting NCT06113965 - Neural Operant Conditioning N/A
Recruiting NCT06448260 - Outcome of a Cohort of Patients Fitted With a SYME Type Prosthesis in the Context of a Hindfoot Amputation With Distal Support
Recruiting NCT06420752 - Passive Stretching in Peripheral Arterial Disease Patients Phase 2
Recruiting NCT05710029 - Cortical Processes During Walking Post-stroke
Not yet recruiting NCT06454656 - A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy N/A
Recruiting NCT04947865 - Reflex Excitability in Post-stroke Stiff-Knee Gait N/A
Recruiting NCT06399900 - ENhancing Exercise With LIGHT to Improve Functioning in PAD N/A
Not yet recruiting NCT06399809 - Fisetin to Reduce Senescence and Mobility Impairment in PAD Phase 2